Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fish oil study

This article was originally published in The Tan Sheet

Executive Summary

Fish oil supplements did not protect against irregular heartbeats for patients with implantable cardioverter-defibrillators (ICDs), according to a study published in the Journal of the American Medical Association June 14. The year-long study involved 546 patients with ICDs and prior documented incidences of ventricular tachycardia (VT) or ventricular fibrillation (VF) who received either two grams of fish oil per day, or placebo. Trial endpoints were appropriate ICD intervention for VT or VF, or all-cause mortality. In the fish oil group, 27% required ICD intervention for VT or VF versus 30% in the placebo group. "In contrast to other...[studies], we did not find that fish oil may have proarrhythmic properties," Ingeborg Brouwer, PHD, Wageningen University, the Netherlands, et al., state...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS099472

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel